Atlas Trials

Effect of Dapagliflozin on Electrocardiographic Parameters in Type 2 Diabetes Patients: DAPA - ECG Study

Clinical trial NCT06721442 · COMPLETED

Trial details

NCT number
NCT06721442
Sponsor
Beneficência Portuguesa de São Paulo
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Arrhythmias, CardiacDiabetes Mellitus
Start date
2023-01-10
Primary completion
2023-12-10
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.